Persistence with denosumab therapy in women affected by osteoporosis with fragility fractures: a multicenter observational real practice study in Italy

References

Page 1

	Year	Citations
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis Steven R. Cummings, Javier San Martín, Michael R. McClung, New England Journal of Medicine	2009	3.4K
Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial Jacques P. Brown, Richard L. Prince, Chad Deal, Journal of Bone and Mineral Research Total HipGynecologyPharmacotherapyOrthopaedic SurgeryOsteoporosis	2008	595
Comparing Adherence and Persistence Across 6 Chronic Medication Classes Jason Yeaw, Joshua S. Benner, John G. Walt, Journal of Managed Care Pharmacy	2009	547
Health-Related Quality of Life in Postmenopausal Women With Low BMD With or Without Prevalent Vertebral Fractures Anna Oleksik, Paul Lips, Alison Dawson, Journal of Bone and Mineral Research	2000	510
Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy David L. Kendler, Christian Roux, Claude Laurent Benhamou, Journal of Bone and Mineral Research Bone DiseaseAdverse EventsBone HealthPharmacologyBone Mineral Density	2009	447
The Impact of Monitoring on Adherence and Persistence with Antiresorptive Treatment for Postmenopausal Osteoporosis: A Randomized Controlled Trial Jackie A. Clowes, Nicola Peel, Richard Eastell The Journal of Clinical Endocrinology & Metabolism	2004	332
Determinants of adherence to osteoporosis treatment in clinical practice Maurizio Rossini, Gerolamo Bianchi, Ombretta Di Munno, Osteoporosis International Preventive MedicineOsteopathyOutcomes ResearchOsteopathic MedicineOsteoporosis	2006	290
Effect of Dosing Frequency on Bisphosphonate Medication Adherence in a Large Longitudinal Cohort of Women Robert R. Recker, Rich Gallagher, Paul E. MacCosbe Mayo Clinic Proceedings Family MedicineSubstance AbuseHealth PolicyBisphosphonate Medication AdherencePharmacoepidemiology	2005	250
Compliance with pharmacologic therapy for osteoporosis Robert A. Yood, Srinivas Emani, John I. Reed, Osteoporosis International Bone DiseaseBone HealthMedicinePharmacologic TherapyOsteoarthritis	2003	197
Determinants of persistence with bisphosphonates: A study in women with postmenopausal osteoporosis Fernie J. A. Penning‐van Beest, Wim Goettsch, Joëlle A. Erkens, Clinical Therapeutics Bone DiseaseBone HealthOrthopaedic SurgeryMedicineGynecology	2006	144

Page 1